Athera Biotechnologies' Grant

Athera Biotechnologies raised a round of funding on June 19, 2013. Investors include Seventh Framework Programme.

Athera Biotechnologies develops a biomarker and companion diagnostic VCDefine kit. The biomaker, anti-PC, is linked to increased risk for cardiovascular disease and could in the future be used for ide…

Articles about Athera Biotechnologies' Grant: